Previous Article | Next Article 
Molecular and Cellular Biology, November 2000, p. 8397-8408, Vol. 20, No. 22
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Cdc13 Cooperates with the Yeast Ku Proteins and
Stn1 To Regulate Telomerase Recruitment
Nathalie
Grandin,
Christelle
Damon, and
Michel
Charbonneau*
Ecole Normale Supérieure, UMR CNRS/ENS
5665, Lyon 69364, France
Received 18 May 2000/Returned for modification 7 July 2000/Accepted 22 August 2000
 |
ABSTRACT |
The Saccharomyces cerevisiae CDC13 protein binds
single-strand telomeric DNA. Here we report the isolation of new mutant
alleles of CDC13 that confer either abnormal telomere
lengthening or telomere shortening. This deregulation not only depended
on telomerase (Est2/TLC1) and Est1, a direct regulator of
telomerase, but also on the yeast Ku proteins, yKu70/Hdf1 and
yKu80/Hdf2, that have been previously implicated in DNA repair and
telomere maintenance. Expression of a Cdc13-yKu70 fusion protein
resulted in telomere elongation, similar to that produced by a
Cdc13-Est1 fusion, thus suggesting that yKu70 might promote
Cdc13-mediated telomerase recruitment. We also demonstrate that Stn1 is
an inhibitor of telomerase recruitment by Cdc13, based both on
STN1 overexpression and Cdc13-Stn1 fusion experiments. We
propose that accurate regulation of telomerase recruitment by Cdc13
results from a coordinated balance between positive control by yKu70
and negative control by Stn1. Our results represent the first evidence
of a direct control of the telomerase-loading function of Cdc13 by a
double-strand telomeric DNA-binding complex.
 |
INTRODUCTION |
Telomeres, the ends of eukaryotic
chromosomes, are critical for maintaining chromosome stability and
genome integrity (2, 8, 60). Telomeres are composed of
particular DNA sequences which are rich in TG and arranged in
species-specific repeated motifs. Telomeres are capped by proteins that
bind to these repeating DNA sequences (6, 20). This
apparently serves at least two distinct purposes. First, some of these
telomeric proteins presumably form complexes that regulate telomerase
activity and, hence, the length of telomeric tracts (31,
43). Some telomeric proteins have also been implicated in the
physical protection of chromosome ends (38), in preventing
recombinational events that would otherwise frequently occur between
repeating telomeric sequences (33, 34, 53), and in keeping
off DNA repair enzymes (14). Indeed, telomeres represent
naturally occurring DNA double-strand breaks that, contrary to those
resulting from accidental damage, do not need to (and must not) be
repaired. Surprisingly, however, yeast Ku proteins, as well as proteins
of the Mre11-Rad50-Xrs2 complex, which have been implicated in DNA
repair by nonhomologous end joining have also been implicated in
telomere maintenance (3, 4, 7, 11, 12, 27, 28, 39, 44, 46,
47). Moreover, yKu70 and yKu80 have been found to localize at the
telomeres (18, 37).
The repeating TG-rich telomeric DNA sequences are mostly double
stranded. However, during S phase only, telomeres display a short (ca.
35- to 50-nucleotide) single-stranded DNA extension that marks the very
end of the telomere (57, 58). Single-stranded telomeric DNA
is thought to represent the site of anchoring of telomerase, which is
composed of the evolutionary conserved Est2 reverse transcriptase
enzyme and of the TLC1 RNA template (31, 42).
However, recent experiments suggest that telomerase-dependent elongation of de novo ends does not appear to involve single
strandedness and does not require significant degradation prior to
addition of newly synthesized telomeric DNA (9). Est1 and
Est3 represent two subunits of the telomerase complex (25, 29,
55), which although not required for in vitro telomerase
catalytic activity (32), are nevertheless stable components
of the enzyme and regulate its activity in vivo through physical
association with Est2 and TLC1 (25, 61).
Cdc13 was the first identified single-strand DNA-binding telomeric
protein in Saccharomyces cerevisiae and, consequently, its
status as a candidate for most of telomeric functions has become
prominent (5, 14, 30, 45). The isolation of the cdc13-2/est4-1 allele, which confers a strong deficit in
telomerase activity (29), as well as the recent finding that
a fusion protein made of Cdc13 plus Est1 could bypass
telomerase-defective mutations in either protein, strongly suggests
that interactions between Cdc13 and Est1 represent the mechanism by
which a number of regulators can control telomerase recruitment
(10). Indeed, physical association between Cdc13 and Est1
has been revealed recently (48). Cdc13 has also been shown
to bind Pol1 in vivo, and it has been proposed that Cdc13 might
coordinate regulation at the telomere ends of G-strand lengthening by
telomerase, via Est1, and C-strand resynthesis by polymerase
(48). In addition, the observation that the temperature-sensitive cdc13-1 allele displays abnormal
accumulation of single-stranded DNA specifically at telomeric regions
of chromosomes argued that Cdc13 might be a major telomeric capping
protein (14). It has also been observed that when Cdc13 was
defective, in cdc13-1 cells, the absence of either yKu70 or
yKu80, which was otherwise dispensable, impaired growth (44,
46). The yKu proteins, which bind to double-stranded telomeric
DNA, have been proposed to be involved in establishing the proper
terminal DNA structure of chromosomes in cooperation with telomerase
(18, 46). In addition to its nonessential function in the
recruitment of telomerase at telomere ends (45), Cdc13
has an essential function that has not yet been clearly defined.
cdc13-1 mutant cells are temperature sensitive and present a
first cell cycle arrest at restrictive temperatures of growth
(14).
In the present study, we have isolated several new mutant alleles of
CDC13 which confer either abnormal telomere elongation or,
on the contrary, telomere shortening. Telomere elongation in these
novel cdc13 alleles was found to be more affected by mutations in either YKU70 or YKU80 than by
mutations in TEL1 or RAD50, therefore implicating
the yeast Ku proteins in the telomerase-loading function of Cdc13. This
was supported by observing telomere elongation as a direct result of
the expression of a Cdc13-yKu70 fusion protein, which is comparable in
length to that produced by a Cdc13-Est1 fusion. We also present
evidence, based on overexpression of Stn1 or expression of Stn1-Cdc13
fusions, that Stn1, a protein that associates with Cdc13 by two-hybrid
interaction (17), is an inhibitor of telomerase recruitment
via Cdc13. We propose that Cdc13 is both a positive and a negative
regulator of telomerase recruitment, which establishes
differential interactions with other telomeric proteins, and
that the balance between these two opposing effects principally relies
on interactions with yKu70 or yKu80 and with Stn1.
 |
MATERIALS AND METHODS |
Strains, plasmids, and media.
General plasmids and media
used in this study were as described previously (17).
Disruptions of TLC1, EST1, RAD50,
YKU70, or YKU80 in wild-type,
cdc13-1, or cdc13-109i strains were achieved following transformation of linearized
tlc1::LEU2 (52),
est1::URA3 (55),
rad50::hisG-URA3-hisG
(41), yku70/hdf1::URA3
(47), or yku80::TRP1 (see
below) DNA fragments. The correct disruptions were detected on Southern
blots. In some cases, these disruption strains were further mixed with
other mutations by genetic crosses. The
tel1::kanMX4 (strain record number
3114; Research Genetics, Inc., Huntsville, Ala.) and
rad52-7::LEU2 (strain record number XS560-1C-1D1; Yeast Genetic Stock Center, Berkeley, Calif.) disruption strains were backcrossed five times against the genetic background used
in our lab (17). The
cdc13::TRP1 disruption plasmid was constructed by inserting TRP1 at the BamHI site
of CDC13, at nucleotide 1349, and the
yku80::TRP1 disruption plasmid was
constructed by inserting TRP1 between the XbaI
and AccI sites (nucleotides 84 to 1762) of YKU80.
The cdc13-109 integrated allele was constructed by the
pop-in-pop-out method. To do this, cdc13-109 was cloned into a URA3 integrative plasmid (YIp211) which was then used
to transform a wild-type strain. The Ura+ transformants
were then grown on 5-fluoro-orotic acid (5-FOA) plates to counterselect
for cells that, together with the URA3 marker gene, had lost
one copy of the CDC13 gene (either the wild-type or the
mutant copy). Telomere length was then monitored on Southern blots in
several of these Ura
cells after a few generations of
growth (see below). Only half of these colonies displayed elongated
telomeres, with the other half exhibiting telomeres of wild-type size.
Cells with elongated telomeres were selected, and the presence of only
one copy of the CDC13 gene was verified by Southern blot.
This suggested that cells with elongated telomeres had integrated the
cdc13-109 allele at the CDC13 locus, while cells
with wild-type telomeres had, on the contrary, evicted the
cdc13-109-URA3 integrated construct. Integration of the
cdc13-69 allele at the CDC13 locus was performed using the same methodology as for cdc13-109.
Construction and selection of cdc13 alleles and of
stn1-63.
CDC13 open reading frame (ORF) plus 300 bp
upstream of the ATG was amplified by PCR under mutagenic conditions, as
described previously for STN1 (17) in standard
PCR buffer supplemented with MnCl2, using standard
Taq polymerase (Gibco-BRL). Following two rounds of PCR
mutagenesis, using the products of the first reaction as a template for
the second reaction, the PCR products were cleaned and used directly to
transform a cdc13-1 strain, together with a single-copy,
centromeric, plasmid, YCp111-LEU2 (15), made
linear by digestion and carrying CDC13 flanking regions at
each extremity (gap repair method). The 5' fragment of these flanking
regions consisted of the 964 bases before the start codon plus the 57 bases after, while its 3' fragment comprised the 690 bases before the
stop codon plus the 830 bases after. Cells were then plated onto
leucine-lacking (Leu
) medium and incubated at 25°C
until colonies of transformants developed. Because the objective of
CDC13 mutagenesis was to uncover non-temperature-sensitive
alleles deregulated in telomere length control, transformants were then
replica plated on Leu
medium at 32 and 34°C,
temperatures of growth restrictive for cdc13-1. This allowed
us to select for mutagenized CDC13 plasmids capable of
sustaining growth of the cells bearing them in the absence of
functional endogenous Cdc13 protein, because the Cdc13-1 protein is
inactivated at temperatures higher than 28°C in our genetic
background (17). Among several thousands of such colonies growing at 32 or 34°C, 121 were picked out randomly and separately grown for further analysis of the length of their telomeric tracts (see
below). The most interesting YCp111-borne cdc13 alleles, in
terms of telomere length deregulation, were then recovered from the
original cdc13-1 recipient strain and used to retransform the cdc13-1 strain. Genomic DNA from transformants grown for
about 100 generations was then prepared, and the lengths of the
telomeric tracts were analyzed by Southern blotting, as explained below.
The stn1-63 allele was generated by PCR mutagenesis,
followed by gap repair, under conditions described previously
(17). The stn1::TRP1 strain
bearing the stn1-63 allele on a YCp111-LEU2 plasmid was selected (after eviction of the wild-type STN1
allele carried by a YCp33-URA3 plasmid on 5-FOA-containing
medium) among several tens of other potential stn1 mutant
strains on the basis of telomere length deregulation, as directly
measured on Southern blots, as described below.
For sequence analysis of the cdc13 alleles, the ORFs of the
mutant CDC13 genes, cloned into YEp195-GAL1 (an
episomal, 2µ, URA3 plasmid), were digested with
EcoRI, taking advantage of the presence of two natural
EcoRI sites in the CDC13 sequence. This generated
three pieces of CDC13 ORF roughly equal in size, which were
then subcloned into pBluescript. DNA sequencing was performed in a
semiautomated DNA sequencer (Applied Biosystems) using T3 or T7 primer
as the sequencing primer.
Measurement of telomere length.
Genomic DNA was prepared as
described previously (17), digested with XhoI and
separated by electrophoresis in a 0.9% agarose gel in
Tris-borate-EDTA. After denaturation, DNA was transferred onto
nitrocellulose membrane and immobilized by baking at 80°C for 1 h under a vacuum (1). The membrane was then prehybridized in
6× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% sodium dodecyl sulfate-1% nonfat milk and hybridized with a 270-bp TG1-3 32P-labeled probe representing S. cerevisiae telomeric sequences. Results were analyzed using a
Storm PhosphorImager (Molecular Dynamics).
Control experiments in which DNA fragments after XhoI
cutting were separated under denaturing conditions (1% agarose gel run in 40 mM NaOH-2 mM EDTA) were performed to ensure that both
single-stranded and double-stranded modifications in telomere length
were detected (see also reference 17).
Construction of fusion proteins.
Cdc13-Est1, Cdc13-69-Est1,
Cdc13-yKu70, Cdc13-yKu80, Cdc13-Stn1-63, and Cdc13-231-Stn1 in-frame
fusion proteins were constructed by cloning in a single-copy,
centromeric, plasmid the entire CDC13 ORF (or the
cdc13-69 or cdc13-231 ORFs) plus upstream
promoter sequences in front of the EST1, YKU70,
YKU80, or STN1 (wild-type or mutant) ORF (which
included their natural stop codons). The yKu80-Cdc13 fusion protein was
constructed by cloning in a single-copy plasmid the entire
YKU80 ORF plus upstream promoter sequences in front of
CDC13, so as to keep a continuous reading frame. The CEN plasmids used in the present study are of the YCplac
series and are single-copy plasmids (15), just like the
CEN plasmid, pRS415 (51), used by Evans and
Lundblad (10). Telomere elongation by the Cdc13-Est1 fusion
protein was not due to increased protein expression because
overexpression of CDC13 or EST1 had no effect on
telomere length (10, 17). Moreover, the functionality of the
Cdc13-Est1 fusion protein was attested to by its ability to assume the
essential function of Cdc13 (rescue of cdc13-1 cells at a
restrictive temperature or of cdc13
cells) and to rescue the senescence phenotype of an
est1::URA3 mutant.
Epitope tagging, Western blot detection, and band shift
experiments.
The 10 cdc13 mutant DNAs corresponding to
the mutant strains described in the present study were subcloned into a
YEp195-GAL1 (2µ, URA3) plasmid under the
control of the strong, inducible, GAL1 promoter. In this
plasmid the natural stop codon of the cdc13 mutant genes was
eliminated so as to obtain a continuous reading frame between the Cdc13
protein and a 2HA-6His epitope tag (16). This allowed
visualization of the Cdc13 mutant proteins by Western blotting using
monoclonal anti-hemagglutinin antibody (12CA5; Boehringer). The
presence of this epitope tag also allowed purification of the Cdc13
mutant proteins by Ni chromatography directed against the
His6 part of the tag, using Qiagen reagents. After transfer to nitrocellulose membrane (Schleicher & Schuell), proteins were detected using an enhanced chemiluminescence system (ECF; Amersham) coupled with detection in a Storm PhosphorImager (Molecular Dynamics).
For band shift experiments and detection by Western blotting, wild-type
cells bearing, on a YEp195-GAL1-URA3 plasmid, wild-type CDC13 or a cdc13 mutant allele fused in 3' with a
2HA-6His epitope were grown overnight, in liquid cultures, in
glucose-based minimal medium lacking uracil. Cdc13 protein expression
was then induced for 4 h at 30°C after shifting the cells to
Ura
galactose-containing medium following four or five
washes in galactose-based medium. Cells were then harvested by
centrifugation, and extracts were prepared in band shift lysis buffer
(50 mM NaH2PO4-Na2HPO4 buffer, pH 8.0; 30 mM NaCl; 10 mM Na imidazole) supplemented with protease inhibitors (1% phenylmethylsulfonyl fluoride and 10 µg each
of aprotinin, leupeptin, and pepstatin per ml). Approximately 500 µg
of the total proteins were then incubated with Ni-nitrilotriacetic acid
beads (Qiagen) for 2 h at 4°C. Nickel beads were then washed three times in 50 mM
NaH2PO4-Na2HPO4 buffer
(pH 8.0), 20 mM Na imidazole, and 0.5% Tween 20 and then once in 50 mM
NaH2PO4-Na2HPO4 buffer
(pH 8.0) and 20 mM Na imidazole. Cdc13-2HA-6His proteins were then
eluted in 50 µl of 50 mM
NaH2PO4-Na2HPO4 buffer
(pH 8.0)-250 mM Na imidazole. Binding reactions were performed in 50 mM Tris-HCl buffer (pH 7.5), 1 mM EDTA, 50 mM NaCl, 1 mM
dithiothreitol, 1 µg of single-stranded poly(dI-dC) using 2 to 4 µl
of eluted protein, and 1 ng of 32P-labeled
(TG1-3)3 (TGTGTGGGTGTGTGGGTGTGTGGG)
for 20 min at 30°C. A monoclonal anti-HA antibody (12CA5) was
used at 0.5 µg per reaction. After the addition of 1 µl of 10%
glycerol, the reactions were loaded on a 4.5% polyacrylamide gel that
was run for 2 h at 4°C. Gels were then dried and analyzed using
a Storm PhosphorImager (Molecular Dynamics).
 |
RESULTS |
New telomere-shortening and telomere-elongating cdc13
alleles.
To better understand the role of Cdc13 at telomeres, we
set out to generate new alleles of CDC13 using PCR
amplification under mutagenic conditions (see Materials and Methods)
and reintroduce them into a conditional system provided by a
cdc13-1 mutant strain (14). cdc13-1
cells stop growing at temperatures above 23 to 25°C (14)
or above 27 to 28°C in our genetic background (17). Among
several thousand transformants of cdc13-1 capable of growth at 32 or 34°C, 121 were picked randomly for further study. Genomic DNA was prepared, and the lengths of the telomeric tracts were measured
by probing total XhoI-digested genomic DNA with a
32P-labeled TG1-3 telomeric probe, as
described in Materials and Methods. Only mutant strains with
substantial changes in telomere length were selected for further
analysis, namely, cdc13-7, cdc13-109, cdc13-231, and cdc13-276, which are
telomere-elongating alleles, and cdc13-23,
cdc13-30, cdc13-69, cdc13-243,
cdc13-273, and cdc13-280, which are
telomere-shortening alleles (Fig. 1A).

View larger version (56K):
[in this window]
[in a new window]
|
FIG. 1.
Telomere lengthening associated with the
cdc13 alleles relies on telomerase activity and requires
Est1. (A) Telomere Southern blot analysis of novel
non-temperature-sensitive cdc13 mutant alleles generated by
PCR mutagenesis (see Materials and Methods) reveals the possibility of
a large panel of telomere size deregulation when CDC13 is
mutated (lanes 2 to 14) compared to a wild-type strain (lane 1). Here,
the cdc13 alleles (names of which are indicated on top of
the figure) were present on a single-copy centromeric plasmid in a
cdc13-1 mutant. These mutant strains were grown at 32°C to
inactivate Cdc13-1. (B) Augmentation of telomerase activity is
responsible for telomere elongation in the new cdc13 mutant
strains described here. TLC1, the RNA subunit of telomerase,
was disrupted directly in a cdc13-109i mutant or in a
cdc13-1 mutant harboring YCp-cdc13-276. The
resulting strains no longer displayed the telomere elongation conferred
by the cdc13-109 and cdc13-276 mutations, as
measured here after approximately 50 generations (compare lane 2 to
lane 3 and lane 5 to lane 6). Telomere lengths in wild-type strains
(lanes 1 and 4) are shown for comparison. (C) Telomere elongation in
the cdc13 mutants necessitates the presence of Est1, a
regulator of telomerase. The EST1 gene was genetically
disrupted in cdc13-109i or in cdc13-1
YCp-cdc13-276 and telomere size measured after approximately
50 generations. Absence of telomere lengthening in the resulting double
mutants (compare lane 2 to lane 3 and lane 4 to lane 5) was observed.
(D) The Cdc13-109 and Cdc13-231 mutant proteins can sustain growth on
their own when expressed from a single-copy plasmid in a strain
disrupted for CDC13
(cdc13::TRP1). Both Cdc13-109 (lane 3)
and Cdc13-231 (lane 4) conferred telomere lengthening compared to a
wild-type strain (lane 1) or a cdc13 disruptant expressing
wild-type CDC13 (lane 2). (E) Expression of the
temperature-sensitive cdc13-1 allele from an episomal
plasmid, at the restrictive temperature of 34°C, had no incidence on
the cdc13-109-associated telomere lengthening (compare lanes
2 and 3).
|
|
Since we suspected that the Cdc13-1 mutant protein might have some
residual activity at 32 to 34°C, we next tested whether the isolated
cdc13 alleles were capable of sustaining growth on their
own. To this end, we attempted to replace the genomic copy of
CDC13 by each one of these cdc13 alleles using
the pop-in-pop-out method (see Materials and Methods). Concerning the
telomere-elongating alleles (telomere-shortening alleles will be
examined below), we were successful in recovering cells that had
integrated a mutant copy of cdc13-109 (from now on referred
to as cdc13-109i) at the CDC13 genomic locus. The
Cdc13-109 mutant protein in the cdc13-109i strain could
assume the essential function of Cdc13 while harboring long telomeres
similar to those in the cdc13-1 strain bearing the
cdc13-109 allele on a centromeric plasmid (Fig. 1A and B). In terms of growth and cellular morphology, the cdc13-109i
strain was indistinguishable from a wild-type strain (data not shown). We were not successful at obtaining replacements with the other three
selected telomere-elongating cdc13 alleles.
In another approach to characterize these telomere-elongating
cdc13 alleles, we constructed a cdc13 disruption
strain (cdc13::TRP1), that survived
owing to a single-copy URA3 plasmid expressing wild-type CDC13, which was then transformed with one of the four
selected cdc13 alleles carried by a single-copy plasmid.
After eviction of the CDC13-URA3 plasmid on 5-FOA-containing
medium, the cdc13::TRP1 YCp-cdc13-109 and
cdc13::TRP1 YCp-cdc13-231
strains were viable and exhibited telomeres of a length similar to that
in the respective original strains in a cdc13-1 background
at 32-34°C (Fig. 1A and D), while the
cdc13::TRP1 YCp-cdc13-7 and
the cdc13::TRP1
YCp-cdc13-276 strains were not viable (data not shown).
To serve as a control for some of the experiments that have been
performed in a cdc13-1 background (see below), we measured telomere length in the cdc13-109i strain transformed with
cdc13-1 on an episomal plasmid. Importantly, at 32 or
34°C, telomeres in this strain were the same length as those in the
cdc13-109i strain (Fig. 1E) and as those in the
cdc13-1 strain harboring cdc13-109 on a
centromeric plasmid (Fig. 1A). These control experiments establish that
the presence of the Cdc13-1 mutant protein at 32 to 34°C has no
effect on telomere length while, on the other hand, it may provide, at
these temperatures, a residual Cdc13 activity allowing growth of
strains harboring the cdc13-7 and cdc13-276 mutations which are otherwise unable to sustain growth on their own.
Telomere elongation in the new cdc13 mutants depends on
telomerase and requires Est1.
Because both telomerase-dependent
and telomerase-independent mechanisms, in the latter case relying on
homologous recombination, can regulate telomere size (33,
34), we next asked which one of these two mechanisms affected
telomere regulation in the telomere-elongating cdc13 mutants
described here. To do this, we introduced a null mutation in
TLC1, the RNA subunit of telomerase essential for telomerase
activity (52), into the cdc13-109i mutant (see
Materials and Methods) and measured telomere size in the resulting
double mutants. The typical telomere elongation observed in the
cdc13-109i was not observed in the cdc13-109i
tlc1
mutants (Fig. 1B). These results were confirmed using the
cdc13-1 YCp-cdc13-276 strain (Fig. 1B). Because
the homologous recombination mechanisms controlling telomere length are
entirely dependent on Rad52, we then analyzed telomere size
deregulation in cdc13-109i rad52
or cdc13-1
YCp111-cdc13-276 rad52
mutant strains and found that they
displayed telomeres elongated to the same extent as that in the
corresponding RAD52+ strains (data not shown).
It has been recently demonstrated that Cdc13
regulates telomerase recruitment via functional
interaction with Est1 (10, 48, 55). We found that telomere
elongation associated with the cdc13-109i and
cdc13-276 mutations was suppressed in the absence of Est1
(Fig. 1C), implying that Est1 is necessary for abnormal telomere
lengthening in the cdc13-109i and cdc13-276
mutants. These results also suggest that regulation of telomerase
recruitment by wild-type Cdc13 requires Est1.
The telomere-elongating Cdc13 mutant proteins still associate with
telomeric DNA.
To determine whether the telomere length phenotype
could be merely due to a defect of the Cdc13 mutant proteins in binding telomeric DNA (5, 26, 30), band shift experiments were performed using Cdc13-2HA-6His mutant proteins purified by Ni chromatography (see Materials and Methods). The Cdc13-109 and Cdc13-231
proteins were still be able to bind telomeric DNA (Fig. 2A). The specificity of these
interactions was evidenced by visualizing supershifts when a monoclonal
anti-HA antibody was added to the reaction (Fig. 2A). Careful
examination of the intensities of the DNA-protein bands revealed that
the Cdc13-109 and Cdc13-231 mutant proteins were only partially
competent in binding telomeric DNA compared to wild-type Cdc13 (Fig.
2).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 2.
The telomere-elongating Cdc13 mutant proteins described
in this study are still able to bind telomeric sequences. (A) The in
vitro binding of wild-type Cdc13 and of telomere-elongating Cdc13
mutant proteins to specific TG1-3 telomeric DNA sequences
was measured by assessing gel retardation of Cdc13-2HA-6His proteins
(see Materials and Methods). The same reaction mixtures were incubated
in parallel with a monoclonal anti-HA antibody, which generated a
supershift of the complex attesting of the specificity of the
DNA-protein binding reaction. Binding of the Cdc13-109-2HA-6His and
Cdc13-231-2HA-6His proteins was somewhat weaker than that of
wild-type Cdc13-2HA-6His, while Cdc13-7-2HA-6His and
Cdc13-276-2HA-6His did not bind telomeric DNA. Unlabeled arrows
indicate the position of the DNA-protein and DNA-protein-antibody
complexes. (B) Immunoblot analysis, using a monoclonal anti-HA
antibody, of crude extracts from cells expressing Cdc13-2HA-6His
proteins under the control of the inducible GAL1 promoter
was performed essentially to assess the presence of the Cdc13 mutant
proteins used in band shift experiments. This analysis revealed that,
in fact, Cdc13-7 and Cdc13-276 were not produced as entire proteins.
Sequence analysis of these cdc13 alleles revealed the
presence of a stop codon, generated during mutagenesis, upstream of the
natural stop codon (see text).
|
|
Telomere elongation in the telomere-elongating cdc13
mutants requires both yKu70 and yKu80.
We reasoned that the
telomere-elongating Cdc13 mutant proteins might be deregulated in their
interaction with another telomeric protein. To test this hypothesis,
telomere-elongating alleles of CDC13 were introduced into
mutant strains known to exhibit abnormally short telomeres:
rad50, tel1, yku70/hdf1, and
yku80/hdf2. Rad50 is part of the Mre11-Rad50-Xrs2 telomeric
complex that has been previously shown to function in so-called DNA
nonhomologous end-joining (NHEJ) and in telomere maintenance (21,
28, 44). Tel1 is a telomeric protein that has been implicated in
telomere length regulation and shares homology with the human ATM
proteins (19, 35, 49). The yeast Ku proteins have been
implicated in NHEJ, in heterochromatin organization, in telomere
silencing, and in telomere maintenance (4, 7, 11-13, 18, 22, 37, 39).
Genetic disruption of either RAD50, TEL1,
YKU70, or YKU80 induced telomere shortening (Fig.
3), as previously demonstrated (3,
28, 35, 47). In the cdc13-109i yku70
and
cdc13-109i yku80
double mutants, telomeres were basically
of the same length as those in the yku70
and
yku80
single mutants (Fig. 3A, compare lane 7 to lane 8 and lane 14 to lane 15), whereas telomeres of the cdc13-109i
rad50
double mutant were of an average length intermediate
between those of each of the corresponding single mutants (Fig. 3A,
compare lane 10 to lanes 11 and 12). The effect of tel1
in these experiments was between that of yku70
/yku80
and that of rad50
and was therefore more difficult to
interpret (Fig. 3A, compare lane 1 to lanes 3 and 4). However, careful
examination of the data revealed that the upper limit of the smear
defining the average value of the bulk of telomere lengths was much
higher in cdc13-109i tel1 cells than in cdc13-109i
yku70 or cdc13-109i yku80 cells (Fig. 3A). These
observations were confirmed by experiments using the
cdc13-276 mutant (Fig. 3B).

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Mutations in YKU70 or YKU80 have a
larger suppressing effect on cdc13-109- or
cdc13-276-associated telomere elongation than mutations in
RAD50 or TEL1. (A) cdc13-109i tel1
(lane 1), cdc13-109i yku70 (lane 7), cdc13-109i
rad50 (lane 10), and cdc13-109i yku80 (lane 14) double
mutants were grown for approximately 100 generations, and their
telomere lengths were compared to those in the corresponding single
mutants (neighboring lanes in each panel for each of the four
mutations) and in wild-type cells (lanes 2, 5, 9, and 13). See the text
for interpretation of the data. (B) cdc13-1 rad50 ,
cdc13-1 tel1 , cdc13-1 yku70 , and
cdc13-1 yku80 double mutants were propagated at 25°C
and transformed with a single-copy plasmid harboring the
cdc13-276 allele. The resulting triple mutants were grown at
34°C to inactivate Cdc13-1, and the sizes of their telomeres were
measured after approximately 100 generations (lanes 3, 6, 10, and 14)
and compared to those in cdc13-1 rad50, cdc13-1
tel1, cdc13-1 yku70, or cdc13-1 yku80 (lanes
2, 5, 8, and 13), respectively, at 34°C or to that in wild-type
isogenic strains (lanes 1, 4, 7, and 11). Telomere lengths in
cdc13-1 cells grown at 25°C (lane 12) and in
cdc13-1 cells harboring cdc13-276 on a
single-copy plasmid, grown at 34°C (lane 9), served as negative and
positive controls, respectively. Note that cdc13-1 yku70
YCp-cdc13-276 (lane 10) and cdc13-1 yku80
YCp-cdc13-276 cells (lane 14) no longer displayed the long
telomere phenotype characteristic of the cdc13-276 allele
(lane 9), contrary to cdc13-1 rad50 YCp-cdc13-276
(lane 3) and cdc13-1 tel1 YCp-cdc13-276 (lane 6)
which did. This interpretation is confirmed by visualizing the dots in
lane 10, which highlight two bands corresponding to two non Y'
telomeres. These were also present in wild-type cells (lane 7) and
yku70 cells (lane 8) but were absent from cells harboring
the cdc13-276 mutation alone (lane 9). This confirmed that
the telomere structure in the cdc13-1 YCp-cdc13-276
yku70 mutant no longer resembled that in cdc13-1
YCp-cdc13-276 but was instead similar to that in wild-type
cells. The same held true for yku80 (lane 14) but not for
rad50 (lane 3) and tel1 (lane 6) cells. See
the text for further explanations. Conditions of strain culturing were
as described above.
|
|
A Cdc13-yKu70 fusion protein induces abnormal telomere
lengthening.
Because the genetic interactions described above were
only indicative of a potential functional relationship between Cdc13 and either yKu70 or yKu80, we decided to adopt a complementary approach. One of our hypotheses to explain these interactions relied on
the existence of a physical interaction between either yKu70 or yKu80
and Cdc13. Because attempts to detect physical association between
Cdc13 and yKu70 in a two-hybrid system failed (unpublished results), we
decided to use a method recently applied with success in the analysis
of interactions between Cdc13 and Est1 (10), which consists
in the expression of fusion (hybrid) proteins. We first expressed a
Cdc13-Est1 fusion protein from a single-copy centromeric plasmid under
the control of the CDC13 promoter (see Materials and
Methods) and observed that it produced telomere elongation in a
CDC13+ EST1+ strain, an
effect that was much more pronounced in a cdc13-1 background
at 34°C or in cdc13::TRP1 than in a
wild-type background (Fig. 4A, lanes 2, 8, and 11), as described recently (10).

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 4.
A Cdc13-yKu70 fusion protein produces telomere
elongation that is dependent on Est1. (A) Expression of
CDC13-EST1 or CDC13-YKU70 hybrid gene from a
single-copy centromeric plasmid under the control of the
CDC13 promoter for approximately 100 generations, either in
a cdc13-1 strain grown at 34°C to inactivate Cdc13-1 (left
panel), in a wild-type background (middle left panel), or in a
cdc13-1 background (middle right panel) provoked dramatic
telomere elongation (lanes 2, 5, 8, 9, 11, and 12) compared to controls
(cdc13-1 cells grown at 25°C, lane 1; wild-type cells,
lanes 7 and 10). A fusion consisting of the telomere-shortening
Cdc13-69 mutant protein and of either wild-type Est1 or wild-type yKu70
also produced telomere elongation in cdc13 (lanes 16 and
17) or cdc13-1 at 34°C (lanes 3 and 6), therefore
indicating rescue of the short telomere phenotype conferred by Cdc13-69
(lane 15). A Cdc13-Stn1 fusion (lane 13) served as a negative control.
(B) Telomere elongation provoked by the Cdc13-yKu70 fusion no longer
took place in the absence of Est1 (lane 6; compare to the est1 [lane 5] and wild-type [lane
4] strains). Lanes 1 and 3, in which CDC13 or
EST1 alone were expressed, provided additional controls for
these protein fusion experiments. See the text for further
explanations. (C) Telomere elongation provoked by the Cdc13-yKu70 no
longer took place in yku80 cdc13-1 cells
(lane 1; compare to the YKU80+ cdc13 cells
expressing the same fusion (lane 2) and to the wild-type [lane 3] and
yku80 [lane 4] strains). This effect was observed both
in a cdc13 background (lane 1) and a
CDC13+ background (lane 5).
|
|
We then analyzed the effects on telomere length of expressing a
Cdc13-yKu70 fusion protein from a single-copy plasmid under the control
of the CDC13 promoter. The Cdc13-yKu70 fusion protein was
fully functional because it rescued the nonviability of
cdc13
cells as well as the growth defect of
yku70
cells at 37°C (13) (data not shown).
Expression of the Cdc13-yKu70 fusion resulted in telomere elongation in
cdc13
and CDC13+ cells, as well as
in cdc13-1 cells grown at 34°C (Fig. 4A, lanes 5, 9, and
12). In all backgrounds (CDC13+,
cdc13-1, and cdc13
), expression of the
Cdc13-yKu70 fusion lengthened telomeres to a lesser extent than that of
the Cdc13-Est1 fusion (Fig. 4A). Importantly, the Cdc13-yKu70 did not
cause telomere elongation in a strain disrupted for EST1
(Fig. 4B, lane 6). This suggested that the artificially introduced
Cdc13-yKu70 hybrid protein affected telomerase recruitment via Est1. On
the other hand, telomere elongation due to the Cdc13-Est1 fusion still
took place in a strain disrupted for YKU70 to the same
extent as that in a YKU70+ strain (Fig. 4A,
compare lanes 3 and 4). In addition, expression of CDC13 or
EST1 alone from a single-copy plasmid in a cdc13-1 yku70
strain (Fig. 4B, lanes 1 and 3) provided controls for the experiments shown above.
Because yKu70 and yKu80 are active in DNA repair only as a
heterodimeric complex (12, 39), we measured the effect of
expressing a Cdc13-yKu80 fusion protein on telomere length.
Surprisingly, expression of a Cdc13-yKu80 fusion protein expressed from
a single-copy centromeric plasmid under the control of the
CDC13 promoter, although it restored inviability of
cdc13-1 cells at 34°C, did not rescue the
yku80
-induced telomere shortening (data not shown). We
therefore constructed another hybrid protein which this time consisted
of a yKu80-Cdc13 fusion protein expressed from a single-copy
centromeric plasmid under the control of the YKU80 promoter.
The yKu80-Cdc13 fusion rescued the inviability of cdc13
cells but only partially the short telomere phenotype of
yku80
(telomeres were of a heterogenous size, forming a
smear whose upper limit reached the wild-type size and lower limit the
yku80
size; data not shown). On the other hand, the
yKu80-Cdc13 fusion produced only a moderate lengthening of telomeres in
cdc13
cells (data not shown). Because of the lack of full
functionality of the Cdc13-yKu80 and yKu80-Cdc13 fusions, one cannot
conclude whether the absence of a drastic effect on telomere length of
these fusions is real or not.
Finally, we asked whether the Cdc13-yKu70 fusion could produce telomere
lengthening in the absence of yKu80. Interestingly, a yku80
cdc13
double mutant expressing the Cdc13-yKu70 under the
conditions described above (see Fig. 4A) did not display any significant change in telomere length, unlike the
YKU80+ cdc13
YCp-Cdc13-yKu70 strain, which
clearly exhibited telomere elongation (Fig. 4C, compare lanes 1 and 2).
These experiments suggest that telomere elongation induced by the
Cdc13-yKu70 fusion requires the presence of yKu80.
Novel nonsenescent telomere-shortening cdc13 alleles
are severely defective in DNA-binding activity.
None of the
telomere-shortening cdc13 alleles described in this
study (see Fig. 1A), namely, cdc13-23, cdc13-30,
cdc13-69, cdc13-243, cdc13-273, and
cdc13-280, provoked senescence (29, 33, 34) in
contrast to cdc13-2/est4-1 cells or tlc1
cells (data not shown). To further characterize these novel
telomere-shortening Cdc13 mutant proteins, we performed band shift
experiments to measure their ability to bind telomeric DNA (Fig.
5A). All six telomere-shortening Cdc13
mutant proteins were severely defective in binding telomeric DNA (Fig.
5A). Among these, Cdc13-69-2HA-6His Cdc13-243-2HA-6His, and
Cdc13-273-2HA-6His retained some DNA binding activity, as confirmed by
observing a supershifted band upon addition of anti-HA antibody during
the reaction, while the Cdc13-23-2HA-6His, Cdc13-30-2HA-6His, and
Cdc13-280-2HA-6His proteins were almost completely defective in
binding telomeric DNA (Fig. 5A).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
In vitro binding of telomere-shortening Cdc13 mutant
proteins to specific TG1-3 telomeric DNA sequences. (A)
Band shift experiments, performed as described in the legend to Fig. 2,
revealed that all six Cdc13 mutant proteins were severely defective in
DNA binding, with Cdc13-23-2HA-6His, Cdc13-30-2HA-6His, and
Cdc13-280-2HA-6His being more affected than Cdc13-69-2HA-6His,
Cdc13-243-2HA-6His, and Cdc13-273-2HA-6His, which still showed some
binding. The specificity of the DNA-protein interaction was attested to
by visualizing a supershift upon addition of a monoclonal anti-HA
antibody to the reaction mixture. Unlabeled arrows indicate the
position of the DNA-protein and DNA-protein-antibody complexes. (B)
Western blot analysis of crude extracts from cells expressing
Cdc13-2HA-6His proteins under the control of the inducible
GAL1 promoter, using a monoclonal anti-HA antibody, revealed
that basically all of the Cdc13 mutant proteins were produced to the
same extent within the cell, with the exception of Cdc13-243-2HA-6His,
whose levels were lower than those of the other mutant proteins. (C)
The cdc13-69i strain, harboring the telomere-shortening
cdc13-69 allele integrated at the CDC13 locus,
exhibited telomeres shortened to the same extent as those in a
cdc13-1 YCp-cdc13-69 strain grown at 34°C (Fig.
1A, lane 12) or in a cdc13 YCp-cdc13-69 strain
(Fig. 4A, lane 15).
|
|
Among the six telomere-shortening cdc13
alleles, cdc13-69 conferred the largest telomere shortening
effect (Fig. 1A). Integration of cdc13-69 at the
CDC13 genomic locus (to create cdc13-69i)
demonstrated that the Cdc13-69i protein could assume Cdc13's essential
function (no apparent defect; data not shown) and conferred a short
telomere phenotype similar in amplitude to that conferred by Cdc13-69
(compare lane 12 in Fig. 1A to lane 2 in Fig. 5C).
It has been shown that Cdc13-2, the only other Cdc13 mutant protein
known to confer telomere shortening, was capable of binding telomeric
DNA (45) and Est1 (48). It is important to note that a Cdc13-69-Est1 fusion protein conferred telomere lengthening, by
a just slightly smaller degree than that produced by the Cdc13-Est1 fusion (Fig. 4A, lane 16), thus suggesting that increased association between Cdc13-69 and Est1 could cure the telomere size regulation defect of the Cdc13-69 mutant protein. However, because Est1 is also a
single-strand telomeric DNA-binding protein (55), it is not
possible yet to decide whether the defect of Cdc13-69 is in its ability
to bind telomeric DNA, a defect rescued by Est1-mediated recruitment to
DNA, or rather lies in a putative physical interaction with Est1.
Expression of a Cdc13-69-yKu70 fusion also rescued the short telomere
phenotype conferred by the cdc13-69 allele (Fig. 4A, compare
lanes 15 and 17), thus supporting the model that yKu70 promotes the
Cdc13-mediated recruitment of telomerase.
Stn1 exerts a negative effect on Cdc13-mediated telomerase
loading.
We have previously proposed that Stn1 might negatively
regulate Cdc13 activity (17). In view of the potential
positive modulation of Cdc13 activity by yKu70, we speculated that Stn1
might feed negative signals into the Cdc13-regulating machinery. In our
previous studies on Stn1 (17), it had not been demonstrated
that a loss of Stn1 function led to deregulation of telomerase
recruitment. We now demonstrate that the telomeric defect of
stn1-13, a mutant which exhibits a severe growth defect at
the restrictive temperature of 37°C and telomere elongation at any
temperature between 25 and 37°C (17), results from a
deregulation in telomerase recruitment and/or activity (Fig.
6A).

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 6.
Stn1 behaves as an inhibitor of telomerase recruitment.
(A) A "young" stn1-13 mutant strain (in which the
stn1-13 mutation had been introduced at the STN1
locus only for a week so as to obtain cells with telomeres of nearly
wild-type size) was disrupted for TLC1 and grown at 30°C
for approximately 50 generations. In this stn1-13
tlc1::LEU2 strain, telomeres remained short
(lane 4), of the same size as in a wild-type strain disrupted for
TLC1 (lane 2), and shorter than in wild-type
TLC1+ cells (lane 1), in contrast with telomeres
in stn1-13 TLC1+ cells which during the same
period of growth had become very long (lane 3). (B) Overexpression of
STN1 diminishes the cdc13-276-associated telomere
elongation and aggravates the cdc13-273-associated telomere
shortening. A cdc13-1 YCp-cdc13-273 mutant was
transformed with YEp-STN1, a multicopy plasmid
overexpressing STN1 under the control of its natural
promoter (lane 3), or with vector alone (lane 2). Both strains were
grown at 32°C (to inactivate Cdc13-1), and the size of their
telomeres were measured after approximately 100 generations. Short
telomeres conferred by the Cdc13-273 protein (lane 2; compare to the
telomere size in a cdc13-1 strain grown at 25°C [lane
1]) were further shortened following STN1 overexpression
(lane 3). In addition, abnormal telomere lengthening conferred by the
Cdc13-276 mutant protein (lane 4) was partially relieved when
STN1 was overexpressed (lane 5).
|
|
Because Stn1 loss of function leads to telomerase hyperactivation,
Stn1, which physically associates with Cdc13 by two-hybrid interaction
(17, 54), might be a negative regulator of Cdc13. If so,
overexpression of STN1 might be able to modify telomere length regulation. Overexpression of STN1 from a multicopy
(episomal, 2µ) plasmid under the control of its natural promoter
produced no visible effect on telomere length in a wild-type strain
(data not shown), as described previously (17). However,
when STN1 was overexpressed in a mutant strain expressing
the telomere-shortening cdc13-273 allele from a single-copy
plasmid, a further increase in telomere shortening was observed (Fig.
6B, compare lanes 2 and 3). Likewise, overexpression of STN1
in a mutant strain expressing the telomere-elongating
cdc13-276 allele from a single-copy plasmid resulted in a
noticeable slowing down of telomere elongation (Fig. 6B, compare lanes
4 and 5). On the basis of these experiments, one can conclude that Stn1
behaves as an inhibitor of telomerase recruitment.
A possible mechanism accounting for the observations described above
consists of direct titration of Cdc13 by Stn1. To test this prediction,
we designed the following fusion protein experiments. Expressing a
fusion protein made of Cdc13-231 and Stn1 in a cdc13
strain resulted in a dramatic suppression of telomere elongation conferred by the Cdc13 mutant protein (Fig.
7A, compare lanes 2 and 3). Thus, it
appears that the defect of the Cdc13-231 protein in telomere length
regulation can be totally corrected by providing a more permanent
association between wild-type Stn1 and the Cdc13-231 mutant protein. As
an important control, we verified that
YCp111-cdc13-231-induced telomere elongation was not
compromised by a fusion with Est1 (data not shown). Interestingly, a
fusion between wild-type Cdc13 and wild-type Stn1 provoked a small
shortening of telomeres (Fig. 4A, lane 13).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
Expression of Stn1-Cdc13 fusion proteins confirm that
Stn1 negatively regulates Cdc13. (A) Expression of a
cdc13-231-STN1 hybrid gene from a single-copy centromeric
plasmid under the control of the CDC13 promoter in a
cdc13 strain grown for approximately 100 generations
totally suppressed the long telomere phenotype conferred by Cdc13-231
(compare lanes 2 and 3). (B) Expression of a CDC13-stn1-63
hybrid gene in an stn1 strain under the same conditions
as those described above totally suppressed the telomere lengthening
phenotype conferred by Stn1-63 (compare lanes 2 and 3), which resulted
in the acquisition of telomeres of wild-type size (lane 1).
|
|
We next examined the consequences of fusing an Stn1 mutant protein
conferring telomere elongation to wild-type Cdc13. To do this, we used
stn1-63, a mutant that was generated using a PCR-based methodology (see Materials and Methods). The strain harboring stn1-63 carried on a centromeric plasmid
(YCp111-LEU2) in an stn1 null background
(stn1::TRP1) was selected on the basis
of its deregulation in telomere length. The stn1-63 mutant
strain had no visible morphological or growth defect at temperatures
between 25 and 37°C (data not shown). The constitutive defect in
telomere size of stn1-63 cells, namely, a very dramatic
increase in telomere length (Fig. 7B, lane 2), is comparable to that in
stn1-13 cells growing at 34°C (17). As shown
above for stn1-13 (Fig. 6A), telomere lengthening conferred
by stn1-63 was found to depend entirely on telomerase (data
not shown). Introduction of the gene encoding the Cdc13-Stn1-63 fusion
carried by a single-copy plasmid under the control of the
CDC13 promoter into an stn1
strain almost totally suppressed telomere elongation conferred by Stn1-63 (Fig. 7B,
compare lanes 2 and 3). This observation suggests that the defect of
the Stn1-63 protein, which as far as we know about Stn1 function
(17; present data) might be a failure to properly
regulate Cdc13, can be almost totally corrected by artificially
increasing its association with Cdc13 by means of a fusion protein.
Sequence analysis of the cdc13 alleles.
DNA
sequencing revealed that all six sequenced cdc13 alleles
(cdc13-7, cdc13-69, cdc13-109,
cdc13-243, cdc13-273, and cdc13-276) contained multiple point mutations. In addition, a mutation in lysine
706 of Cdc13-276 introduced a termination codon that resulted in the
truncation of the last 218 amino acids, while a frameshift in
cdc13-7 sequence at lysine 702 led to the introduction of a premature stop codon at amino acid 721. We have not been able so far to
identify the mutations responsible for the phenotypes of the
corresponding mutants.
 |
DISCUSSION |
The survival of an organism relies on the proper duplication,
segregation, and stability of its genome. Telomeres play an important
role in maintaining chromosome structure because, for instance,
chromosomes that lose a telomere are themselves eliminated from the
cell (50). In yeast, mutations in telomerase components or
regulators produce a gradual erosion of chromosomes that eventually leads to death by senescence due to chromosome instability (29, 34). Cdc13 has been previously implicated, together with Est1, as
the main regulator of telomerase access to telomeric ends (10, 30, 45, 48, 61).
The present study extends our knowledge on the role of Cdc13 in
telomerase control through the analysis of novel cdc13
alleles and their functional relationships with mutations in other
telomeric proteins. Our data suggest that the yeast Ku proteins,
previously implicated in DNA repair and telomere maintenance in yeast
and humans (4, 7, 16, 24, 27, 37, 39), promote telomerase recruitment by Cdc13. Our results also demonstrate that regulation by
yKu70 or yKu80 is opposite of that by Stn1, since we found that Stn1
negatively regulates Cdc13-mediated telomerase recruitment. The present
study also provides telomere-shortening cdc13 alleles that
do not confer senescence and may be useful in some biochemical or
genetic assays.
Stn1 inhibits telomerase recruitment via Cdc13.
Our
observation that STN1 overexpression produces telomere
shortening (Fig. 6B) is reminiscent of the effects of overexpressing RIF1 or RIF2 (59). A striking parallel
between these two situations is that Rif1 and Rif2 physically associate
with Rap1, a master regulator of telomere length which binds
double-stranded telomeric DNA (23, 36, 59), while Stn1
physically associates with Cdc13, a master regulator of telomere length
which binds single-stranded telomeric DNA (5, 17, 26, 30,
45). However, a noticeable difference between the two situations
was that STN1 overexpression did not affect telomere length
in wild-type cells (17; the present data), whereas
overexpression of RIF1 and RIF2 did
(59). We propose that overproduction of Stn1 can affect
telomere length only when Cdc13 function is already compromised, as
explained below.
Experiments using fusion proteins further established the role of Stn1
as an inhibitor of Cdc13's telomerase loading function (Fig. 7). As
argued from experiments using Cdc13-Est1 fusion proteins (10), the present data suggest the existence of physical
interactions between Cdc13 and Stn1. Indeed, suppression of the
cdc13-231-induced telomere elongation following
consolidation of its natural interaction with Stn1, as well as
suppression of the stn1-63-induced telomere elongation
following consolidation of its natural interaction with Cdc13, strongly
argue that a major control over Cdc13 activity operates through
physical association with Stn1. In fact, because it is already known
that Stn1 and Cdc13 associate in a two-hybrid system (17,
54), the experiments on Cdc13-Stn1 fusions presented here enhance
interpretations made concerning experiments done with the Cdc13-yKu70
fusion (Fig. 4). It is noticeable that a fusion made of wild-type Cdc13
and wild-type Stn1 provoked a small shortening of telomeres (Fig. 4A,
lane 13), the interpretation of which is discussed below.
yKu70 promotes the recruitment of telomerase by Cdc13.
Disrupting either YKU70 or YKU80 had a larger
suppressing effect on telomere elongation conferred by the Cdc13-276 or
Cdc13-109 mutant proteins than disrupting RAD50 or
TEL1 (Fig. 3). Although at first glance tel1
may appear to have an effect similar to that of yku70
or
yku80
in diminishing the cdc13-109-associated telomere elongation, careful examination of the Southern blot revealed
a difference between the two, which was confirmed in the
cdc13-1 YCp-cdc13-276 strain. It could be argued
that such experiments are difficult to interpret because, for instance, all of the telomere-shortening mutations considered here are in proteins known to be involved each in several pathways, including telomere maintenance. Moreover, since the two mutations present in a
given strain affect telomere length in opposite directions, it is
difficult to determine whether the resulting average telomere length
corresponds to equilibrium between the two opposing effects or rather
reflects actual genetic interaction between the two mutations. For
these reasons, we were very cautious in interpreting these epistasis
experiments. In the end, a noticeable result is that the
yku70
and yku80
mutations totally
suppressed the cdc13-109-induced telomere elongation (Fig.
3A), while conferring wild-type length telomeres to strains bearing the
cdc13-276 mutation (Fig. 3B). The effects of
rad50
and tel1
were smaller than those of
yku70
and yku80
in either cdc13 strain.
Because we did not want to overinterpret the epistasis experiments
discussed above, we used these results only as an indication and not as
a conclusive argument. In fact, the indications provided by these
epistasis experiments were further confirmed by the finding that
expression of a Cdc13-yKu70 fusion protein clearly resulted in telomere
lengthening (Fig. 4). Given that telomere elongation in the
cdc13 alleles described here depends on Est1 (Fig. 1C), altogether these findings suggest that yKu70 and yKu80 may regulate interactions between Cdc13 and telomerase. Importantly, the presence of
yKu80 was necessary to mediate the effect of the Cdc13-yKu80 on
telomere length (Fig. 4C). A possible model is that yKu70 might help
recruit telomerase through an interaction with Cdc13, as explained
below, with yKu80 playing a crucial role in this mechanism as
representing the Ku component attached to telomeric DNA.
A model for the control of Cdc13-mediated telomerase recruitment by
Stn1 and by the yKu70 and yKu80.
Based on the experiments
presented here and the data available in the literature (principally,
references 4, 10, 14, 17, 18, 25, 26, 29, 30, 40, 44-48, 55,
57, and 61), we propose an improved model
for the control of telomerase recruitment by Cdc13 that involves the
existence of a balance between the effects of yKu70 and Stn1 on Cdc13
(Fig. 8). The top panel of Fig. 8 depicts
the situation in wild-type cells, while the bottom panels propose two
hypotheses to account for the situation encountered in the
cdc13-109i mutant strain.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 8.
(Top) A speculative model for yKu70 and Stn1 as positive
and negative regulators, respectively, of Cdc13-Est1-mediated
telomerase loading in wild-type cells. Stn1, which physically
associates with Cdc13, a single-strand telomeric DNA-binding protein,
acts as an inhibitor of Cdc13-mediated telomerase recruitment
(telomerase contains the catalytic subunit, Est2, and TLC1,
the RNA template; Est1, a regulator of telomerase which binds
single-stranded telomeric DNA, also physically associates with
TLC1). Stn1 release from the Cdc13-Stn1 complex might
represent the signal allowing interactions between Cdc13 and
Est1-telomerase. According to this model, interactions between Cdc13
and the DNA repair yKu proteins, yKu70 and yKu80 (yKu70 physically
associates with yKu80, which itself binds double-strand telomeric DNA),
might promote efficient association of Est1-telomerase with the
telomere end, thus allowing telomeric DNA addition. Re-binding of Stn1
to Cdc13 might compete with Cdc13-yKu70 or -yKu80 and Cdc13-Est1
interactions, therefore breaking interactions between Est1-telomerase
and telomeric DNA and terminating the telomere replication process. (Bottom)
Two hypotheses are proposed to explain the deregulation of telomere
length conferred by the telomere-elongating cdc13 alleles
described in the present study (cdc13-109, which has been
used in most of the experiments presented here, has been chosen for
illustration). For both hypotheses, the situation has been envisioned
either in the presence of the cdc13-109i mutation alone
(cdc13-109 YKU70 cells) or in the simultaneous presence of the
cdc13-109i and the yku70 mutations (cdc13-109
yku70 cells). Full ovals represent a higher than normal physical
association between the deregulated Cdc13-109 mutant protein and yKu70
(hypothesis 1, left) or between Cdc13-109 and Est1 (hypothesis 2, right). In all of the configurations represented here, Stn1 is in the
off position, physically apart from Cdc13, the position that presumably
allows telomerase recruitment by Cdc13. In hypothesis 1 (left),
constitutive interactions between Cdc13 and either yKu70 or yKu80
provokes recruitment of telomerase at higher than normal levels, thus
leading to telomere lengthening (top), while the absence of yKu70
presumably results in inefficient recruitment of Est1-telomerase, thus
suppressing cdc13-109-induced telomere lengthening (bottom).
In hypothesis 2 (right), constitutive interactions between Cdc13 and
Est1 also provoke recruitment of telomerase at higher-than-normal
levels and leads to telomere lengthening (top), but this time the
absence of yKu70 presumably generates an abnormal single-stranded
telomeric DNA extension which competes for Cdc13-109-Est1 interactions
and results in inefficient recruitment of Est1-telomerase and
suppression of the cdc13-109-induced telomere lengthening
(bottom). See the text for further explanations.
|
|
According to our model (Fig. 8, top panel), one might expect Stn1
overproduction to shorten telomeres in wild-type cells, which was not
observed experimentally. In fact, this result can be explained by
assuming that Cdc13 is solidly anchored at telomere ends and that
overproduced Stn1 cannot titrate it out or pull it away from the
telomeres. Under such conditions, only the presence of Stn1, but not
its amount, in close proximity to Cdc13 would be required for the
precise tuning of telomere length control, according to our working
model (Fig. 8, top panel). On the other hand, a Cdc13 mutant protein
exhibiting an altered interaction with another telomeric protein (as
depicted, for instance, for Cdc13-109 in Fig. 8, bottom panels) or
telomeric DNA (as is the case for Cdc13-69; see Fig. 5A), might see its
overall stability affected, thus resulting in competitive inhibition by
Stn1 for the affected binding sites and, hence, in telomere shortening (Fig. 6B). Confirmation of this view must await experimental support.
We observed that expression of a fusion between wild-type Cdc13 and
wild-type Stn1 resulted in a slight shortening of telomeres (Fig. 4A,
lane 13). It is difficult to know whether such a decrease is
significant or not. If it is significant, then expressing a single copy
of the Cdc13-Stn1 fusion gene would be more efficient on Cdc13
regulation than overexpressing STN1. This point of view is
supported by the fact that overexpression of STN1 only
slightly affected telomere length in cdc13 mutant strains
(Fig. 6B), whereas expressing a fusion between a Cdc13 mutant protein
and wild-type Stn1 had a very dramatic effect on telomere length (Fig.
7A). Although these effects are compatible with the model proposed here, it is too early to provide an accurate explanation of the molecular mechanisms involved, particularly since we know that the
defects of the Cdc13 mutant proteins described here are still at the
hypothetical stage (Fig. 8, bottom panels). In addition, full
comprehension of these mechanisms may be complicated by the possible
existence of still-unknown partners of Cdc13 and Stn1.
Because both the Cdc13-yKu70 and the Cdc13-Est1 fusions produced
telomere elongation that mimicked telomere deregulation in the
cdc13 mutants, the corresponding Cdc13 mutant proteins may be deregulated in their interaction with either yKu70 or Est1 (Fig. 8,
bottom panels). On first analysis, a potential defect in the
association of Cdc13 with yKu70 in these cdc13 mutants is
the more plausible explanation (hypothesis 1, Fig. 8, left bottom
panel). Indeed, in the alternative hypothesis
a defect in the
association of Cdc13 with Est1 in these cdc13 mutants
one should not observe a suppressing effect of the yku70
and
yku80
mutations (Fig. 3) unless the yKu proteins directly
interact with telomerase. However, a defect in Cdc13-Est1 interactions
could fit with some other aspects of Ku functions (hypothesis 2, Fig. 8, right bottom panel). Indeed, yeast Ku mutants have been shown to
retain extended TG1-3 tails throughout the cell cycle (46), unlike wild-type cells which retained them only during late S phase (57). It has been proposed that the yeast Ku
proteins are responsible for controlling the 5'-3' processing of
telomere ends (22, 46, 56). Therefore, the absence of the Ku
proteins might structurally modify the telomeric ends so as to produce an alteration of Cdc13 positioning on the 3' free end. Under such conditions, disruption of YKU70 or YKU80 in the
cdc13-109i mutant might result in Cdc13-109 being physically
displaced along the telomere end due to the presence of longer
single-stranded telomeric sequences, which might then, by competitive
interactions, abolish the higher than normal association between
Cdc13-109 and Est1. These hypotheses should now be challenged by
biochemical experiments.
Even though the details of the interactions described here have to be
elucidated in future experiments, our data establish two major
conclusions. First, expression of a Cdc13-yKu70 fusion promotes
telomerase recruitment, which is supported by the finding that, in the
absence of either Ku protein, the Est1-dependent recruitment of
telomerase by Cdc13 is compromised. Second, Stn1 exerts a negative
control over Cdc13-mediated telomerase recruitment.
Stn1 and Rif1 or Rif2 might exert two parallel and complementary levels
of negative control of telomere length, taking place at two spatially
different locations on the telomere. It has been suggested that the
Rap1-dependent telomere length-sensing mechanism (36) might
be mediated by a balance between opposing effects of Rif1 or Rif2 and
those of Sir3 or Sir4 (59). In light of the present data, as
well as of the recent demonstration of a competition between Rif1 or
Rif2 and yKu70 in the recruitment of Sir proteins by Rap1 at the
telomere (40) and of the localization of the Ku proteins
potentially at the junction between double-stranded and single-stranded
telomeric DNA (18, 37), the Ku proteins represent likely
candidates for constituting a functional link between Rap1, Rif1, and
Rif2 and Cdc13 that is capable of modulating telomerase recruitment. If
our hypothesis is correct, the Ku proteins might contribute to control
telomere length by their ability to detect changes in telomere
structure, or even by an ability to modify telomere structure
(46), parameters that would then be fed into the Cdc13
machinery according to mechanisms proposed above. On the other hand,
Stn1 might perceive and convey other types of signals, possibly
emanating from extratelomeric locations. The genetic system described
here, based on the analysis of yeast Cdc13 mutant proteins and their
interaction with other wild-type or mutant telomeric proteins, provides
an excellent frame with which to study the mechanism of telomerase
recruitment at the telomeres.
 |
ACKNOWLEDGMENTS |
We thank James Haber, Sang Eun Lee, Victoria Lundblad, Thomas
Petes, Patricia Greenwell, Ethelle Moustacchi, Daniel Gottschling, Miriam Singer, Leland Hartwell, and Eric Gilson for the gifts of
strains and plasmids. We also thank Eric Gilson for discussion, Catherine Koering for technical advice concerning the band shift experiments, and Suzy Markossian and Armelle Roisin for operating the
semiautomated DNA sequencer.
This work was supported by grants from the Association pour la
Recherche contre le Cancer, the Centre National de la Recherche Scientifique, programme Génome, the Comités
Départementaux de l'Ardèche, la Loire et la Haute-Savoie
de la Ligue Nationale contre le Cancer, and the Région
Rhône-Alpes, programme Apoptose et Vieillissement.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Ecole Normale
Supérieure de Lyon, UMR CNRS 5665, 46, allée d'Italie,
69364 Lyon, France. Phone: (33) 472-72-81-70. Fax: (33) 472-72-80-80. E-mail: Michel.Charbonneau{at}ens-lyon.fr.
 |
REFERENCES |
| 1.
|
Ausubel, F. A.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl (ed.).
1998.
Current protocols in molecular biology.
John Wiley & Sons, Inc., New York, N.Y.
|
| 2.
|
Bodnar, A. G.,
M. Ouellette,
M. Frolkis,
S. E. Holt,
C. P. Chiu,
G. B. Morin,
C. B. Harley,
J. W. Shay,
S. Lichsteiner, and W. E. Wright.
1998.
Extension of life-span by introduction of telomerase into normal human cells.
Science
279:349-352[Abstract/Free Full Text].
|
| 3.
|
Boulton, S. J., and S. P. Jackson.
1996.
Identification of a Saccharomyces cerevisiae Ku80 homologue: roles in DNA double strand break rejoining and in telomeric maintenance.
Nucleic Acids Res.
24:4639-4648[Abstract/Free Full Text].
|
| 4.
|
Boulton, S. J., and S. P. Jackson.
1998.
Components of the Ku-dependent nonhomologous end-joining pathways are involved in telomeric length maintenance and telomeric silencing.
EMBO J.
17:1819-1828[CrossRef][Medline].
|
| 5.
|
Bourns, B. D.,
M. K. Alexander,
A. M. Smith, and V. A. Zakian.
1998.
Sir proteins, Rif proteins, and Cdc13p bind Saccharomyces telomeres in vivo.
Mol. Cell. Biol.
18:5600-5608[Abstract/Free Full Text].
|
| 6.
|
Brun, C.,
S. Marcand, and E. Gilson.
1997.
Proteins that bind to double-stranded regions of telomeric DNA.
Trends Cell Biol.
7:317-324.
|
| 7.
|
Critchlow, S. E., and S. P. Jackson.
1998.
DNA end-joining: from yeast to man.
Trends Biochem. Sci.
23:394-398[CrossRef][Medline].
|
| 8.
|
Cooke, H. J., and B. A. Smith.
1986.
Variability at the telomeres of the human X/Y pseudoautosomal region.
Cold Spring Harbor Symp. Quant. Biol.
51:213-219.
|
| 9.
|
Diede, S. J., and D. E. Gottschling.
1999.
Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases and .
Cell
99:723-733[CrossRef][Medline].
|
| 10.
|
Evans, S. K., and V. Lundblad.
1999.
Est1 and Cdc13 as comediators of telomerase access.
Science
286:117-120[Abstract/Free Full Text].
|
| 11.
|
Feldmann, H., and E.-L. Winnacker.
1993.
A putative homologue of the human autoantigen Ku from Saccharomyces cerevisiae.
J. Biol. Chem.
268:12895-12900[Abstract/Free Full Text].
|
| 12.
|
Feldmann, H.,
L. Driller,
B. Meier,
G. Mages,
J. Kellermann, and E.-L. Winnacker.
1996.
HDF2, the second subunit of the Ku homologue from Saccharomyces cerevisiae.
J. Biol. Chem.
271:27765-27769[Abstract/Free Full Text].
|
| 13.
|
Fellerhoff, B.,
F. Eckardt-Schupp, and A. A. Friedl.
2000.
Subtelomeric repeat amplification is associated with growth at elevated temperature in yku70 mutants of Saccharomyces cerevisiae.
Genetics
154:1039-1051[Abstract/Free Full Text].
|
| 14.
|
Garvik, B.,
M. Carson, and L. Hartwell.
1995.
Single-stranded DNA arising at telomeres in cdc13 mutants may constitute a specific signal for the RAD9 checkpoint.
Mol. Cell. Biol.
15:6128-6138[Abstract].
|
| 15.
|
Gietz, R. D., and A. Sugino.
1988.
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites.
Gene
74:527-534[CrossRef][Medline].
|
| 16.
|
Grandin, N.,
A. de Almeida, and M. Charbonneau.
1998.
The Cdc14 phosphatase interacts with Dbf2 kinase activity during exit from mitosis in Saccharomyces cerevisiae.
Mol. Gen. Genet.
258:104-116[CrossRef][Medline].
|
| 17.
|
Grandin, N.,
S. I. Reed, and M. Charbonneau.
1997.
Stn1, a new Saccharomyces cerevisiae protein, is implicated in telomere size regulation in association with Cdc13.
Genes Dev.
11:512-527 |